INPPL1 and hepatocellular carcinoma: To assess whether expression of SHIP2 is responsive to HBx, we first examined the expression of SHIP2 in HCC cell lines (Hep3B and HepG2, which do not express HBx) and in their derivatives that stably express HBx (Hep3Bx and HepG2x).